Drug Trial Radar · NCT05398679
Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis
Last checked: Nov 19, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Aug 17, 2022
Primary completion
Dec 30, 2026
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- Fundacion Clinic per a la Recerca BiomédicaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 1, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective endocarditis
Conditions
- Endocarditis Infective
Interventions
CefaclorDrug
cefaclor intravenous 2 gr/day
Ciprofloxacin TabletsDrug
500-750 mg/12 hrs (maximum 3g x day)
Ciprofloxacin InjectionDrug
1200 mg/day maximum dose IV
Clindamycin Oral CapsuleDrug
600 mg/8 hours (maximum 1.800 mg x day)
Clindamycin InjectionDrug
600 mg/8 hours (maximum 1.800 mg x day) IV
Dicloxacillin Oral CapsuleDrug
1g/8 hours (maximum 4 gr day)
DicloxacillinDrug
1g/8 hours (maximum 4 g x day) IV
Fusidic Acid Only Product in Oral Dose FormDrug
0,750g/12 hours (maximum 1,5 g x day)
Fusidic Acid Only Product in Parenteral Dose FormDrug
0,75 g/12 hours (maximum 1,5 g x day)
Levofloxacin Oral TabletDrug
0.5g/12-24hours (maximum 1 g x day)
Levofloxacin InjectionDrug
0.5g/12-24hours (maximum 1 g x day)
Linezolid Oral TabletDrug
0,6 g/12 hours (maximum 1200 mg x day)
Linezolid Injectable ProductDrug
0,6 g/12 hours (maximum 1200 mg x day)
Moxifloxacin tabletDrug
0,4 g/day (maximum 400 mg x day)
Moxifloxacin Injectable ProductDrug
0,4 g/day (maximum 400 mg x day)
Rifampicin Only Product in Oral Dose FormDrug
0,3-0,5 g/12 hours (maximum 1200 mg x day)
Rifampicin Only Product in Parenteral Dose FormDrug
0,3-0,6 g/12 hours (maximum 1200 mg x day)
Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]Drug
sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)
Sulfamethoxazole / Trimethoprim Injectable ProductDrug
sulfamethoxazole 1600 mg/trimethoprin 320 mg (maximum x day)
Tedizolid Oral TabletDrug
200 mg tedizolid (maximum x day)
Tedizolid InjectionDrug
200 mg (maximum x day)
Amoxicillin CapsulesDrug
1 gr/6 hours (4 g x day)
AmoxicillinDrug
1 gr/6 hours (4 g x day) Intravenous
Cefaclor CapsulesDrug
2 gr/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Non-inferiority of outpatient oral vs parenteral antibiotic therapy measured by the number of unplanned hospitalizationsTime frame: At any time during the study duration (up to 24 months)
- Non-inferiority of outpatient oral vs parenteral antibiotic therapy measured by the number of all-cause mortalityTime frame: At any time during the study duration (up to 24 months)
- Non-inferiority of outpatient oral vs parenteral antibiotic therapy measured by the number of relapses of Infective EndocarditisTime frame: within 6 months from diagnosis of Infective Endocarditis
- Non-inferiority of outpatient oral vs parenteral antibiotic therapy measured by the number of patients requiring cardiac surgeryTime frame: At any time during the study duration (up to 24 months)
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Hospital General de Alicante
Alicante, Alicante, Spain · Recruiting
Hospital Virgen de la Macarena
Seville, Andalusia, Spain · Recruiting
Hospital Virgen del Rocío
Seville, Andalusia, Spain · Recruiting
Hospital Son Espases
Palma de Mallorca, Balearic Islands, Spain · Recruiting
Hospital del Mar
Barcelona, Barcelona, Spain · Recruiting
Hospital Clinic i Provincial de Barcelona
Barcelona, Barcelona, Spain · Recruiting
Hospital Sant Pau
Barcelona, Barcelona, Spain · Recruiting
Hospital Bellvitge
Barcelona, Barcelona, Spain · Recruiting
Parc Taulí Hospital Universitari
Sabadell, Barcelona, Spain · Recruiting
Hospital Mútua de Terrassa
Terrassa, Barcelona, Spain · Recruiting
Hospital Universitario de Cruces
Barakaldo, Bizcaia, Spain · Recruiting
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain · Recruiting
Hospital Universitario de Donostia
Donostia / San Sebastian, Guipuzcoa, Spain · Recruiting
Hospital San Pedro
Logroño, La Rioja, Spain · Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain · Recruiting
Hospital Ramón y Cajal
Madrid, Madrid, Spain · Recruiting
Hospital Universitario La Paz
Madrid, Madrid, Spain · Recruiting
Hospital Virgen de Arrixaca
El Palmar, Murcia, Spain · Recruiting
Hospital universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain · Recruiting
Hospital Universitari i Politècnic La Fe
Valencia, València, Spain · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.